Patterns of respiratory drug use in the Lombardy region of Italy, 1995-1997

European Journal of Epidemiology

Volumn 21, Issue 7, 2006, Pages 537-544

  Vegni, Ferdinando E ^a   Wilkinson, Paul ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Drug utilisation; Prevalence; Respiratory

Indexed keywords

ANTIALLERGIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; NEDOCROMIL; THEOPHYLLINE; XANTHINE DERIVATIVE;

ADULT; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSULTATION; DATA BASE; DISEASE SEVERITY; DRUG USE; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PHARMACY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; INFANT; ITALY; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PRESCRIPTIONS, DRUG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM AGENTS;

EID: 33750048780     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9029-6     Document Type: Article

References (32)

1. Traversa GR, Magrini R, Montanaro N. I cambiamenti nell'uso dei farmaci in Italia. In: Editor ISS, Rome, 1998: 233-256.
2. FederFarma, Assistenza Farmaceutica: Consumi In Aumento, Bologna, 1999.
3. WHO, NIH, NHLBI, Asthma Management and Prevention, Global Initiative for Asthma. WHO, 1998.
4. BTS, Guidelines for COPD. Thorax 1997; 52(Suppl. 5): S1-S28.
5. Direzione Generale Sanità, Regione Lombardia, Salute e Ambiente in Lombardia (secondo Rapporto). 1999.
6. Pahor M, Chrischilles EA, Guralnik JM, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 10(4): 405-411.
7. European-Drug-Index. New York: Elsevier, 1992.
8. Harrison's Principles of Internal Medicine. M. Graw-Hill (Editor), Cambridge, MA 1992: 1047-1053.
9. Dukes MNG (ed). Drug Utilisation Studies, Methods and Uses. vol. 45. W. Europe: WHO Regional Publications (ed), Copenhagen, Denmark: WHO, 1993: 218.
10. Italian-State-Law. Art. 8, Legge 24-12-1993 n.537 e seg.
11. Rolle C, Ferraro L, Marrazzo E, et al. Change in prescribing patterns of general practitioners in Italy before and after the Reform Drug Act. A case study of changes in the city of Turin. Pharm World Sci 1995; 17(5): 158-162.
12. Dipartimento di Farmacologia, Università di Bologna. Rapporto sui farmaci consumati in Regione Emilia Romagna, 1997: Internet www.biocfarm.unibo. it/crevif/osservatorio/: Bologna.
13. Cappellà D, Descriptive tools and analysis. In: Dukes MNG, WHO Europe (eds), Drug Utilisation Studies, Methods and Uses. Copenhagen, Denmark: WHO, 1993: 218.
14. Nordic-Council-on-Medicines. Nordic Statistics on medicines, 1981-1983. Uppsala, 1985.
15. Burney P. Ten years of research on asthma in Europe. The European Community Respiratory Health Survey. Rev Epidemiol Sante Publique 1998; 46(6): 491-496.
16. Woolcock AJ. Worldwide differences in asthma prevalence and mortality. Why is asthma mortality so low in the USA? Chest 1986; 90(Suppl. 5): 40S-45S.
17. [The European Asthma Study. The prevalence of asthma-related symptoms in 5 Spanish areas. The Spanish Group of the European Asthma Study] (Spanish). Med Clin (Barc) 1995; 104(13): 487-492.
18. Campello C, Ferrari M, Poli A, et al. Prevalence of asthma and asthma-like symptoms in an adult population sample from Verona. ECRHS Verona. European Community Respiratory Health Survey. Monaldi Arch Chest Dis 1998; 53(5): 505-509.
19. DeMarco R, Marinoni A, Bugiani M, et al. EC Respiratory Health Surgery in the north of Italy: Methodological problems of a multicenter study of prevalence of asthma. Epidemiol Prev 1994; 18(61): 211-217.
20. Italian Group ECRHS. Prevalence of asthma and asthma symptoms in a general population sample from northern Italy. European Community Respiratory Health Survey - Italy. Allergy 1995; 50(9): 755-759.
21. Agabiti N, Mallone S, Forastiere F, et al. The impact of parental smoking on asthma and wheezing. SIDRIA Collaborative Group. Studi Italiani sui Disturbi Respiratori nell'Infanzia e l'Ambiente. Epidemiology 1999; 10(6): 692-698.
22. Rawson NS, Pearce GL, Inman WH. Prescription-event monitoring: Methodology and recent progress. J Clin Epidemiol 1990; 43(5): 509-522.
23. Tamblyn R, Lavoie G, Petrella L, et al. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995; 48(8): 999-1009.
24. Frischer M, Chapman S, et al. General practice research database for prescribing analysis. Lancet 1998; 351: 453-454.
25. Agenzia per i Servizi Sanitari Regionali. Italia, [report on 1994-1995 quantity and quality drug prescriptions variations in general practices of 9 Italian Regions. Ricerca Sui Servizi Sanitari 1997; 1(Suppl. 1): 1-128.
26. Maggini M, Raschetti R, Traversa G. Drug prescription in Italy. Eur J Clin Pharmacol 1996; 49(6): 429-430.
27. Gentile MP. L'applicazione dei metodi di studio della farmacoepidemiologia in sanità pubblica. Igiene Moderna 1998; 43(1): 15-32.
28. Osborne ML, Vollmer WM, Johnson RE, et al. Use of an automated prescription database to identify individuals with asthma. J Clin Epidemiol 1995; 48(11): 1393-1397.
29. Sorensen HT, Larsen BO. A population-based Danish data resource with possible high validity in pharmacoepidemiological research. J Med Syst 1994; 18(1): 33-38.
30. Shelley M, Croft P, Chapman S, et al. Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? BMJ 1996; 313: 1124-1126.
31. Vegni FE, Pagano A, Amigoni A. [Pharmacoepidemiology of antiasthmatic drugs and air pollution: Preliminary results in the Como Province] XXXVIII Congresso della Società Italiana di Igiene. Ann Ig 1998; 10: 344.
32. Vegni FE, Incorvaia C. The correct prescription of anti-asthmatics by Lombardy paediatricians. Bollettino Epidemiologico della Regione Lombardia 1999; 2: 5-8.